Recent advances in liposome technologies and their applications for systemic gene delivery

Advanced Drug Delivery Reviews

Volumn 30, Issue 1-3, 1998, Pages 73-83

  Chonn, Arcadio ^a   Cullis, Pieter R ^a,b  

^a Inex Pharmaceuticals Corporation   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cationic lipids; DNA encapsulation; Fusogenic liposomes; Intracellular delivery; Liposomal gene delivery systems; Prolonged circulation lifetimes; Targeting; Transfection

Indexed keywords

BIOSYNTHESIS; CELLS; DNA; DRUG PRODUCTS; ENCAPSULATION; GENES; GENETIC ENGINEERING; HEMODYNAMICS; LIPIDS;

CATIONIC LIPIDS; DNA ENCAPSULATION; FUSOGENIC LIPOSOMES; INTRACELLULAR DELIVERY; LIPOSOMAL GENE DELIVERY SYSTEM; PROLONGED CIRCULATION LIFETIMES; TRANSFECTION;

DRUG THERAPY;

DRUG CARRIER; LIPID; LIPOSOME;

DNA TRANSFECTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG PENETRATION; DRUG TRANSPORT; DRUG UPTAKE; ENCAPSULATION; GENE TARGETING; GENE THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0032473563     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00108-7     Document Type: Review

References (104)

1. Chonn A., Cullis P.R. Recent advances in liposomal drug-delivery systems. Curr. Opin. Biotechnol. 6:1995;698-708.
2. Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. TIBTECH. 13:1995;527-537.
3. Schwartz G.K., Casper E.S. A phase II trial of doxorubicin HCl liposome injection in patients with advanced pancreatic adenocarcinoma. Invest. New Drugs. 13:1995;77-82.
4. Treat J., Greenspan A., Forst D., Sanchez J.A., Ferrans V.J., Potkul L.A., Woolley P.V., Rahman A. Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J. Natl. Cancer Inst. 82:1990;1706-1710.
5. Estey E., Thall P.F., Mehta K., Rosenblum M., Brewer T. Jr., Simmons V., Cabanillas F., Kurzrock R., Lopez-Berestein G. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans-retinoic acid. Blood. 87:1996;3650-3654.
6. Wasan K.M., Lopez-Berestein G. The past, present, and future uses of liposomes in treating infectious diseases. Immunopharmacol. Immunotoxicol. 17:1995;1-15.
7. Gill P.S., Wernz J., Scadden D.T., Cohen P., Mukwaya G.M., von Roenn J.H., Jacobs M., Kempin S., Silverberg I., Gonzales G.et al. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J. Clin. Oncol. 14:1996;2353-2364.
8. Mayer L.D., Masin D., Nayar R., Boman N.L., Bally M.B. Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours. Br. J. Cancer. 71:1995;482-488.
9. Webb M.S., Harasym T.O., Masin D., Bally M.B., Mayer L.D. Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models. Br. J. Cancer. 72:1995;896-904.
10. Zabner J., Fasbender A.J., Moninger T., Peollinger K.A., Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270:1995;18997-19007.
11. Dowty M.E., Williams P., Zhang G., Hagstrom J.E., Wolff J.A. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4572-4576.
12. Hug P., Sleight R.G. Liposomes for the transformation of eukaryotic cells. Biochim. Biophys. Acta. 1097:1991;1-17.
13. Wolff J.A., Malone R.W., Williams P., Chong W., Ascadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
14. Wolff J., Dowty M., Jiao S., Repetto G., Berg R., Ludtke J., Williams P. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J. Cell Sci. 103:1992;1249-1259.
15. Yoshida M., Mahato R.I., Kawabata K., Takakura Y., Hashida M. Disposition characteristics of plasmid DNA in the single pass rat liver perfusion system. Pharm. Res. 13:1996;599-603.
16. Hickman M.A., Malone R.W., Lehmann-Bruinsma K., Sih T.R., Knoell D., Szoka F.C. Jr., Walzem R., Carlson D.M., Powell J.S. Gene expression following direct injection of DNA into liver. Hum. Gene Ther. 5:1994;1477-1483.
17. Senior J. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:1987;123-193.
18. G. Gregoriadis, Liposome preparation and related techniques, in: G. Gregoriadis, (Ed.), Liposome Technology, Vol. 1, 2nd edition, CRC Press, Boca Raton, FL, 1993, pp. 1-63.
19. Watwe R.M., Bellare J.R. Manufacture of liposomes: a review. Curr. Sci. 68:1995;715-724.
20. van Borssum-Waalkes M., van Galen M., Morselt H., Sternberg B., Scherphof G.L. In vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2′-deoxyuridine and its diacylated derivatives. Biochim. Biophys. Acta. 1148:1993;161-172.
21. Zelphati O., Wagner E., Leserman L. Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes. Antiviral Res. 25:1994;13-25.
22. L.D. Mayer, T.M. Madden, M.B. Bally, P.R. Cullis, pH gradient-mediated drug entrapment in liposomes, in: G. Gregoriadis, (Ed.), Liposome Technology, Vol. 2, 2nd edition, CRC Press, Boca Raton, FL, 1993, pp. 27-44.
23. Hoffman R.M., Margolis L.B., Bergelson L.D. Binding and entrapment of high molecular weight DNA by lecithin liposomes. FEBS Lett. 93:1978;365-368.
24. Mukherjee A.B., Orloff S., Butler J.D., Triche T., Lalley P., Schulman J.D. Entrapment of metaphase chromosomes into phospholipid vesicles (lipochromosomes): carrier potential in gene transfer. Proc. Natl. Acad. Sci. U.S.A. 75:1978;1361-1365.
25. Mannino R.J., Allebach E.S., Strohl W.A. Encapsulation of high molecular weight DNA in large unilamellar phospholipid vesicles. FEBS Lett. 101:1979;229-232.
26. Schaefer-Ridder M., Wang Y., Hofschneider P.H. Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. Science. 215:1982;166-168.
27. Nicolau C., Le Pape A., Soriano P., Fargette F., Juhel M.F. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc. Natl. Acad. Sci. U.S.A. 80:1983;1068-1072.
28. Baru M., Axelrod J.H., Nur I. Liposome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice. Gene. 161:1995;143-150.
29. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA transfection procedure. Proc. Natl. Acad. Sci. U.S.A. 84:1987;7413-7417.
30. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., Ramsey P., Martin M., Felgner P.L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269:1994;2550-2561.
31. Gao X., Huang L. Cationic liposome-mediated gene transfer. Gene Ther. 2:1995;710-722.
32. Balasubramaniam R.P., Bennett M.J., Aberle A.M., Malone J.G., Nantz M.H., Malone R.W. Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. Gene Ther. 3:1996;163-172.
33. Gershon H., Ghirlando R., Guttman S.B., Minsky A. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry. 32:1993;7143-7151.
34. Gustafsson J., Arvidson G., Karlsson G., Almgren M. Complexes between cationic liposomes and DNA visualized by cryo-TEM. Biochim. Biophys. Acta. 1235:1995;305-312.
35. Sternberg B., Sorgi F.L., Huang L. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett. 356:1994;361-366.
36. Lew D., Parker S.E., Latimer T., Abai A.M., Kuwahara-Rundell A., Doh S.G., Yang Z., Laface D., Gromkowski S.H., Nabel G.J., Manthorpe M., Norman J. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6:1995;553-564.
37. Thierry A.R., Lunardi-Iskandar Y., Bryant J.L., Rabinovich P., Gallo R.C., Mahan L.C. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc. Natl. Acad. Sci. U.S.A. 92:1995;9742-9746.
38. Liu Y., Liggitt D., Zhong W., Tu G., Gaensler K., Debs R. Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270:1995;24864-24870.
39. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 261:1993;209-211.
40. Gao X., Huang L. Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry. 35:1996;1027-1036.
41. Lee R.J., Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 271:1996;8481-8487.
42. Hofland H.E., Shephard L., Sullivan S.M. Formation of stable cationic lipid/DNA complexes for gene transfer. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7305-7309.
43. F. Liu, J. Yang, L. Huang, D. Liu, New cationic lipid formulations for gene transfer, Pharm. Res. (1997), in press.
44. F. Liu, J. Yang, L. Huang, D. Liu, Effect of non-ionic surfactants on the formation of DNA/emulsion complex and the emulsion-mediated gene transfer, Pharm. Res. (1997), in press.
45. Reimer D.L., Zhang Y., Kong S., Wheeler J.J., Graham R.W., Bally M.B. Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA. Biochemistry. 34:1995;12877-12883.
46. Wong F.M.P., Reimer D.L., Bally M.B. Cationic lipid binding to DNA: characterization of complex formation. Biochemistry. 35:1996;5756-5763.
47. Allen T.M., Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett. 223:1987;42-46.
48. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-237.
49. Blume G., Cevc G. Liposomes for the sustained drug release in vivo. Biochim. Biophys. Acta. 1029:1990;91-97.
50. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., Martin F.J. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U.S.A. 88:1991;11460-11464.
51. Needham D., McIntosh T.J., Lasic D.D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta. 1108:1992;40-48.
52. Semple S., Chonn A. Protein-liposome interactions in relation to clearance. J. Liposome Res. 6:1996;33-60.
53. Senior J., Delgado C., Fisher D., Tilcock C., Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta. 1062:1991;77-82.
54. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6949-6953.
55. Bakker-Woundenberg I.A.J.M., Lokerse A.F., Ten-Kate M.T., Storm G. Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. Biochim. Biophys. Acta. 1138:1992;318-326.
56. Wu N.Z., Da D., Rudolf T.L., Needham D., Whorton A.R., Dewhirst M.W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res. 53:1993;3765-3770.
57. Mahato R.I., Kawabata K., Nomura T., Takakura Y., Hashida M. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J. Pharm. Res. 84:1995;1267-1271.
58. Osaka G., Carey K., Cuthbertson A., Godowski P., Patapoff T., Ryan A., Gadek T., Mordenti J. Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [P-33]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J. Pharm. Sci. 85:1996;612-618.
59. Plank C., Mechtler K., Szoka F.C. Jr., Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7:1996;1437-1446.
60. A. Mori, A. Chonn, L.S. Choi, A. Israels, M.A. Monck, P.R. Cullis, In vivo stabilization and regulated fusion of liposomes containing a cationic lipid using amphipathic polyethyleneglycol derivatives, submitted.
61. Holland J.W., Hui C., Cullis P.R., Madden T.D. Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry. 35:1996;2618-2624.
62. Holland J.W., Cullis P.R., Madden T.D. Poly(ethylene glycol)-lipid conjugates promote bilayer formation in mixtures of non-bilayer-forming lipids. Biochemistry. 35:1996;2610-2617.
63. Zhou X., Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochim. Biophys. Acta. 1189:1994;195-203.
64. Farhood H., Serbina N., Huang L. The role of dioleoylphosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta. 1235:1995;289-295.
65. Ahmad I., Longenecker M., Samuel J., Allen T.M. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res. 53:1993;1484-1488.
66. Mori A., Kennel S.J., Van Borssum-Waalkes M., Scherphof G.L., Huang L. Characterization of organ-specific immunoliposomes for delivery of 3′,5′-O-dipalmitoyl-5-fluoro-2′-deoxyuridine in a mouse lung-metastasis model. Cancer Chemother. Pharmacol. 35:1995;447-456.
67. HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1327-1331.
68. Allen T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 15:1994;215-220.
69. H.C. Loughrey, L.S. Choi, K.F. Wong, P.R. Cullis, M.B. Bally, Preparation of streptavidin-liposomes for use in ligand specific targeting applications, in G. Gregoriadis, (Ed.), Liposome Technology, Vol. 3, 2nd edition, CRC Press, Boca Raton, FL, 1993, pp. 163-178.
70. Blume G., Cevc G., Crommelin M.D.J.A., Bakker-Woudenberg I.A.J.M., Kluft C., Storm G. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta. 1149:1993;180-184.
71. Lee R.J., Low P.S. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J. Biol. Chem. 269:1994;3198-3204.
72. Maruyama K., Takizawa T., Yuda T., Kennel S.J., Huang L., Iwatsuru M. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycols) conjugated at their distal terminals to monoclonal antibodies. Biochim. Biophys. Acta. 1234:1995;74-80.
73. Allen T.M., Brandeis E., Hansen C.B., Kao G.Y., Zalipsky S. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta. 1237:1995;99-108.
74. Sasaki A., Murahashi N., Yamada H., Morikawa A. Synthesis of novel galactosyl ligands for liposomes and the influence of the spacer on accumulation in the rat liver. Biol. Pharm. Bull. 18:1995;740-746.
75. Blom M., Andersson L., Carlsson A., Herslof B., Zhou L., Nilsson A. Pharmacokinetics, tissue distribution and metabolism of intravenously administered digalactosyldiacylglycerol and monogalactosyldiacylglycerol in the rat. J. Liposome Res. 6:1996;737-753.
76. Yamauchi H., Kikuchi H., Sawada M., Tomikawa M., Hirota S. Selective uptake of liposomes containing lactose mono-fatty acid derivatives by hepatic parenchymal cells. J. Microencapsulation. 11:1994;287-296.
77. G. Barratt, F. Schuber, Targeting of liposomes with mannose-terminated ligands, in: G. Gregoriadis, (Ed.), Liposome Technology, Vol. 3, 2nd edition, CRC Press, Boca Raton, FL, 1993, pp. 199-218.
78. Stavridis J.C., Deliconstantinos G., Psallidopoulos M.C., Armenakas N.A., Hadjiminas D.J., Hadjiminas J. Construction of transferrin-coated liposomes for in vivo transport of exogenous DNA to bone marrow erythroblasts in rabbits. Exp. Cell Res. 164:1986;568-572.
79. Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S. Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes. Gene. 159:1995;167-174.
80. Hara T., Kuwasawa H., Aramaki Y., Takada S., Koike K., Ishidate K., Kato H., Tsuchiya S. Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes. Biochim. Biophys. Acta. 1278:1996;51-58.
81. Wrobel I., Collins D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta. 1235:1995;296-304.
82. Labatmoleur F., Steffan A.M., Brisson C., Perron H., Feugeas O., Furstenberger P., Oberling F., Brambilla E., Behr J.P. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther. 3:1996;1010-1017.
83. Cheng P. Receptor ligand-facilitated gene transfer: enhancement of liposome-mediated gene transfer and expression by transferrin. Hum. Gene Ther. 7:1996;275-282.
84. Remy J., Kichler A., Mordvinov V., Schuber F., Behr J. Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1744-1748.
85. Kikuchi A., Sugaya S., Ueda H., Tanaka K., Aramaki Y., Hara T., Arima H., Tsuchiya S., Fuwa T. Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes. Biochim. Biophys. Res. Commun. 227:1996;666-671.
86. Wang C.Y., Huang L. Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry. 28:1989;9508-9514.
87. Kao G.Y., Chang L.J., Allen T.M. Use of targeted cationic liposomes in enhanced DNA delivery to cancer cells. Cancer Gene Ther. 3:1996;250-256.
88. Ellens H., Bentz J., Szoka F.C. Jr. Destabilization of phosphatidylethanolamine liposomes at the hexagonal phase transition temperature. Biochemistry. 25:1986;285-294.
89. II phase transition. Biochemistry. 25:1986;4141-4147.
90. A.M. Tari, F. Zhou, L. Huang, Two types of pH-sensitive immunoliposomes, in G. Gregoriadis, (Ed.), Liposome Technology, Vol. 3, 2nd edition, CRC Press, Boca Raton, FL, 1993, pp. 289-300.
91. Baraka M.E., Pecheur E.I., Wallach D.F.H., Philippot J.R. Non-phospholipid fusogenic liposomes. Biochim. Biophys. Acta. 1280:1996;107-114.
92. Compagnon B., Milhaud P., Bienvenue A., Philippot J.R. Targeting of poly(rI)-poly(rC) by fusogenic (F proteins) immunoliposomes. Exp. Cell Res. 200:1992;333-338.
93. de Fiebre C.M., Bryant S.O., Notabartolo D., Wu P., Meyer E.M. Fusogenic properties of Sendai virosome envelopes in rat brain preparations. Neurochem. Res. 18:1993;1089-1094.
94. Bron R., Ortiz A., Wilschut J. Cellular cytoplasmic delivery of a polypeptide toxin by reconstituted Influenza virus envelopes (virosomes). Biochemistry. 33:1994;9110-9117.
95. Glushakova S.E., Omelyanenko V.G., Lukashevitch I.S., Bogdanov J., Moshnikova A.B., Kozytch A.T., Torchilin V.P. The fusion of artificial lipid membranes induced by the synthetic arenavirus 'fusion peptide'. Biochim. Biophys. Acta. 1110:1992;202-208.
96. Lee K., Oh Y., Portnoy D.A., Swanson J.A. Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J. Biol. Chem. 271:1996;7249-7252.
97. Kato T., Lee S., Ono S., Agawa Y., Aoyagi H., Ohno M., Nishino N. Conformational studies of amphipathic α-helical peptides containing an amino acid with a long alkyl chain and their anchoring to lipid bilayer liposomes. Biochim. Biophys. Acta. 1062:1991;191-196.
98. Puyal C., Maurin L., Miquel G., Bienvenue A., Philippot J. Design of a short membrane-destabilizing peptide covalently bound to liposomes. Biochim. Biophys. Acta. 1195:1994;259-266.
99. K. Vogel, S. Wang, R.J. Lee, P.S. Low, J. Chmielewski, Peptide-mediated release of folate-targeted liposome contents from endosomal compartments, J. Am. Chem. Soc. (1996).
100. Meunier-Durmort C., Ferry N., Hainque B., Delattre J., Forest C. Efficient transfer of regulated genes in adipocytes and hepatoma cells by the combination of liposomes and replication-deficient adenovirus. Eur. J. Biochem. 237:1996;660-667.
101. Kreuzer J., Denger S., Reifers F., Beisel C., Haack K., Gebert J., Kubler W. Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells. Atherosclerosis. 124:1996;49-60.
102. Kaneda Y., Iwai K., Uchida T. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science. 243:1989;375-378.
103. Yanagihara I., Inui K., Dickson G., Turner G., Piper T., Kaneda Y., Okada S. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection. Gene Ther. 3:1996;549-553.
104. Dzau V.J., Mann M.J., Morishita R., Kaneda Y. Fusigenic viral liposome for gene therapy in cardiovascular diseases. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11421-11425.